Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Sagemark Companies was a healthcare services provider specializing in advanced diagnostic imaging. The company's primary business involved the ownership, operation, and management of Positron Emission Tomography (PET) and PET/CT imaging centers. These facilities provided critical diagnostic data for patients in the fields of oncology, cardiology, and neurology. Operating through its subsidiary, Sagemark Health Services, the company partnered with various hospitals and physician groups to deploy high-end imaging technology. Sagemark was previously a publicly traded entity under the ticker SKCO before terminating its registration. The company is currently considered inactive, having ceased its primary business operations in the late 2000s.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Sagemark Companies.